Serina Therapeutics, Inc. SEC filings SER
Serina Therapeutics, Inc. has 519 filings in SEC EDGAR's recent list, going back to Jul 10, 2017. Its latest annual report, Form 10-K, was filed on Mar 25, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 9, 2026 (bylaw or fiscal year change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 3, 2026 | — |
| 8-K |
Current report
Bylaw or fiscal year change
|
Oct 9, 2026 | Oct 5, 2026 |
| 8-K |
Current report
Other events
|
Sep 9, 2026 | Sep 9, 2026 |
| EFFECT | Filing | Aug 31, 2026 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Aug 27, 2026 | Aug 21, 2026 |
| S-1 | Registration statement | Aug 24, 2026 | — |
| S-8 | Employee stock plan registration | Aug 13, 2026 | — |
| 8-K |
Current report
Results of operations
|
Aug 13, 2026 | Aug 13, 2026 |
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 4 | Insider transaction | Jul 23, 2026 | Jul 22, 2026 |
| 3 | Initial insider ownership | Jul 23, 2026 | Jul 22, 2026 |
| 8-K |
Current report
Officer or director change
|
Jul 23, 2026 | Jul 19, 2026 |
| 8-K |
Current report
Officer or director change
|
Jul 22, 2026 | Jul 22, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jul 22, 2026 | — |
| 4 | Insider transaction | Jul 9, 2026 | Jul 7, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jun 24, 2026 | Jun 17, 2026 |
| 4 | Insider transaction | Jun 22, 2026 | May 22, 2026 |
| 4 | Insider transaction | Jun 22, 2026 | Jun 17, 2026 |
| 4 | Insider transaction | Jun 22, 2026 | Jun 17, 2026 |
| 4 | Insider transaction | Jun 22, 2026 | Jun 17, 2026 |
| 4 | Insider transaction | Jun 22, 2026 | Jun 17, 2026 |
| 4 | Insider transaction | Jun 15, 2026 | Jun 11, 2026 |
| EFFECT | Filing | Jun 3, 2026 | — |
| CORRESP | Letter to the SEC | Jun 1, 2026 | — |
| UPLOAD | Letter from the SEC | May 29, 2026 | — |
| 4 | Insider transaction | May 27, 2026 | May 26, 2026 |
| 4 | Insider transaction | May 26, 2026 | May 21, 2026 |
| 4 | Insider transaction | May 26, 2026 | May 21, 2026 |
| 4 | Insider transaction | May 26, 2026 | May 21, 2026 |
| 4 | Insider transaction | May 26, 2026 | May 21, 2026 |
| 4 | Insider transaction | May 26, 2026 | May 21, 2026 |
| 4 | Insider transaction | May 22, 2026 | May 19, 2026 |
| S-3 | Shelf registration | May 22, 2026 | — |
| 8-K |
Current report
Results of operations
|
May 14, 2026 | May 14, 2026 |
| 10-Q | Quarterly report | May 14, 2026 | Mar 31, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | May 4, 2026 | — |
| DEFA14A | Additional proxy material | Apr 28, 2026 | — |
| DEF 14A | Proxy statement | Apr 27, 2026 | Apr 27, 2026 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change
|
Apr 21, 2026 | Apr 15, 2026 |
| 4 | Insider transaction | Apr 21, 2026 | Mar 31, 2026 |
| 4 | Insider transaction | Apr 21, 2026 | Mar 31, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 17, 2026 | Apr 17, 2026 |
| 10-K/A | Amended annual report | Mar 27, 2026 | Dec 31, 2025 |
| S-8 | Employee stock plan registration | Mar 25, 2026 | — |
| 8-K |
Current report
Results of operations
|
Mar 25, 2026 | Mar 25, 2026 |
| 10-K | Annual report | Mar 25, 2026 | Dec 31, 2025 |
| 4 | Insider transaction | Mar 24, 2026 | Mar 23, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
|
Mar 23, 2026 | Mar 17, 2026 |
| 4 | Insider transaction | Mar 20, 2026 | Mar 19, 2026 |
| 4 | Insider transaction | Feb 17, 2026 | Feb 3, 2026 |
| 4 | Insider transaction | Feb 17, 2026 | Feb 3, 2026 |
| 4 | Insider transaction | Feb 17, 2026 | Feb 3, 2026 |
| 4 | Insider transaction | Feb 17, 2026 | Feb 3, 2026 |
| EFFECT | Filing | Feb 13, 2026 | — |
| CORRESP | Letter to the SEC | Feb 11, 2026 | — |
| UPLOAD | Letter from the SEC | Feb 9, 2026 | — |
| 4 | Insider transaction | Feb 3, 2026 | Feb 2, 2026 |
| S-3 | Shelf registration | Jan 30, 2026 | — |
| 4 | Insider transaction | Jan 29, 2026 | Jan 28, 2026 |
| 8-K |
Current report
Other events
|
Jan 28, 2026 | Jan 27, 2026 |
| 4 | Insider transaction | Jan 23, 2026 | Jan 22, 2026 |
| 4 | Insider transaction | Jan 21, 2026 | Jan 20, 2026 |
| 144 | Notice of proposed sale | Jan 20, 2026 | — |
| 8-K |
Current report
Listing notice, Regulation FD disclosure
|
Jan 15, 2026 | Jan 9, 2026 |
| 4 | Insider transaction | Jan 14, 2026 | Jan 13, 2026 |
| 4 | Insider transaction | Jan 9, 2026 | Jan 8, 2026 |
| 4 | Insider transaction | Dec 29, 2025 | Dec 23, 2025 |
| 4 | Insider transaction | Dec 23, 2025 | Dec 22, 2025 |
| 4 | Insider transaction | Dec 17, 2025 | Dec 16, 2025 |
| 4 | Insider transaction | Dec 16, 2025 | Dec 12, 2025 |
| 4 | Insider transaction | Dec 12, 2025 | Dec 11, 2025 |
| 4 | Insider transaction | Dec 11, 2025 | Dec 9, 2025 |
| 8-K |
Current report
Other events
|
Dec 10, 2025 | Dec 10, 2025 |
| 4 | Insider transaction | Dec 4, 2025 | Dec 2, 2025 |
| 4 | Insider transaction | Nov 26, 2025 | Nov 25, 2025 |
| 4 | Insider transaction | Nov 25, 2025 | Nov 24, 2025 |
| 4 | Insider transaction | Nov 19, 2025 | Nov 18, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2025 | Nov 13, 2025 |
| 10-Q | Quarterly report | Nov 13, 2025 | Sep 30, 2025 |
| 4 | Insider transaction | Nov 12, 2025 | Nov 10, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Nov 12, 2025 | Nov 7, 2025 |
| 4 | Insider transaction | Nov 10, 2025 | Nov 7, 2025 |
| 4 | Insider transaction | Nov 10, 2025 | Nov 7, 2025 |
| 4 | Insider transaction | Nov 10, 2025 | Nov 7, 2025 |
| 4 | Insider transaction | Nov 10, 2025 | Nov 7, 2025 |
| 4 | Insider transaction | Nov 10, 2025 | Nov 7, 2025 |
| 4 | Insider transaction | Nov 6, 2025 | Nov 5, 2025 |
| 4 | Insider transaction | Nov 5, 2025 | Nov 4, 2025 |
| 8-K |
Current report
Other events
|
Nov 3, 2025 | Nov 3, 2025 |
| 4 | Insider transaction | Oct 29, 2025 | Oct 28, 2025 |
| 4 | Insider transaction | Oct 28, 2025 | Oct 27, 2025 |
| DEFR14A | Filing | Oct 27, 2025 | — |
| 4 | Insider transaction | Oct 21, 2025 | Oct 20, 2025 |
| 144 | Notice of proposed sale | Oct 14, 2025 | — |
| 4 | Insider transaction | Oct 14, 2025 | Oct 13, 2025 |
| 8-K |
Current report
Other events
|
Oct 6, 2025 | Oct 6, 2025 |
| DEFA14A | Additional proxy material | Sep 26, 2025 | — |
| DEF 14A | Proxy statement | Sep 26, 2025 | Sep 26, 2025 |
| PRE 14A | Preliminary proxy statement | Sep 15, 2025 | Sep 15, 2025 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Sep 15, 2025 | Sep 9, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 9, 2025 | Sep 9, 2025 |
| 4 | Insider transaction | Aug 27, 2025 | Aug 25, 2025 |
| 8-K |
Current report
Other events
|
Aug 25, 2025 | Aug 25, 2025 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Aug 22, 2025 | Aug 18, 2025 |
| 4 | Insider transaction | Aug 20, 2025 | Aug 18, 2025 |
| 4 | Insider transaction | Aug 14, 2025 | Aug 12, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2025 | Aug 11, 2025 |
| 10-Q | Quarterly report | Aug 11, 2025 | Jun 30, 2025 |
| 4 | Insider transaction | Aug 6, 2025 | Aug 4, 2025 |
| 4 | Insider transaction | Jul 30, 2025 | Jul 29, 2025 |
| 4 | Insider transaction | Jul 29, 2025 | Jul 28, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 29, 2025 | Jul 29, 2025 |
| 4 | Insider transaction | Jul 22, 2025 | Jul 21, 2025 |
| 4 | Insider transaction | Jul 17, 2025 | Jul 14, 2025 |
| 4 | Insider transaction | Jul 9, 2025 | Jul 7, 2025 |
| 4 | Insider transaction | Jul 2, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jul 1, 2025 | Jul 1, 2025 |
| 144 | Notice of proposed sale | Jun 30, 2025 | — |
| 4 | Insider transaction | Jun 17, 2025 | May 22, 2025 |
| 3 | Initial insider ownership | Jun 17, 2025 | May 22, 2025 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
|
May 22, 2025 | May 22, 2025 |
| 8-K |
Current report
Results of operations
|
May 8, 2025 | May 8, 2025 |
| 10-Q | Quarterly report | May 8, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Apr 29, 2025 | Apr 25, 2025 |
| EFFECT | Filing | Apr 28, 2025 | — |
| 424B5 | Prospectus supplement | Apr 28, 2025 | — |
| CORRESP | Letter to the SEC | Apr 24, 2025 | — |
| UPLOAD | Letter from the SEC | Apr 23, 2025 | — |
| S-3 | Shelf registration | Apr 18, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 15, 2025 | Apr 15, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
|
Apr 14, 2025 | Apr 8, 2025 |
| EFFECT | Filing | Apr 10, 2025 | — |
| 4 | Insider transaction | Apr 10, 2025 | Apr 8, 2025 |
| 4 | Insider transaction | Apr 10, 2025 | Apr 8, 2025 |
| CORRESP | Letter to the SEC | Apr 8, 2025 | — |
| UPLOAD | Letter from the SEC | Apr 7, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 7, 2025 | Apr 7, 2025 |
| S-8 | Employee stock plan registration | Apr 2, 2025 | — |
| S-3 | Shelf registration | Apr 2, 2025 | — |
| 4 | Insider transaction | Apr 1, 2025 | Mar 28, 2025 |
| 424B3 | Prospectus | Mar 25, 2025 | — |
| POS EX | Filing | Mar 25, 2025 | — |
| 8-K |
Current report
Results of operations
|
Mar 24, 2025 | Mar 24, 2025 |
| 10-K | Annual report | Mar 24, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 24, 2025 | Mar 24, 2025 |
| 4 | Insider transaction | Feb 13, 2025 | Feb 12, 2025 |
| 3 | Initial insider ownership | Feb 13, 2025 | Feb 12, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Feb 12, 2025 | Feb 11, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 3, 2025 | Feb 3, 2025 |
| 4 | Insider transaction | Feb 3, 2025 | Jun 6, 2024 |
| 4 | Insider transaction | Jan 15, 2025 | Jan 14, 2025 |
| 3 | Initial insider ownership | Jan 15, 2025 | Jan 14, 2025 |
| 8-K |
Current report
Officer or director change
|
Jan 15, 2025 | Jan 14, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 6, 2025 | Jan 6, 2025 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets
|
Dec 26, 2024 | Dec 23, 2024 |
| 4 | Insider transaction | Dec 19, 2024 | Dec 17, 2024 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Dec 18, 2024 | Dec 13, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 11, 2024 | Dec 11, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Dec 9, 2024 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Dec 2, 2024 | Nov 26, 2024 |
| 424B3 | Prospectus | Nov 22, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| 8-K |
Current report
Results of operations
|
Nov 12, 2024 | Nov 12, 2024 |
| 10-Q | Quarterly report | Nov 12, 2024 | Sep 30, 2024 |
| ARS | Annual report to shareholders | Nov 6, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Nov 6, 2024 | — |
| DEF 14A | Proxy statement | Nov 6, 2024 | Dec 13, 2024 |
| DEFC14A | Filing | Oct 31, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 2, 2024 | Oct 2, 2024 |
| 4 | Insider transaction | Sep 24, 2024 | Sep 20, 2024 |
| 4 | Insider transaction | Sep 20, 2024 | Sep 18, 2024 |
| 4 | Insider transaction | Sep 16, 2024 | Sep 12, 2024 |
| 8-K |
Current report
Officer or director change
|
Sep 12, 2024 | Sep 8, 2024 |
| 4 | Insider transaction | Sep 11, 2024 | Sep 9, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 5, 2024 | Sep 4, 2024 |
| S-8 | Employee stock plan registration | Aug 23, 2024 | — |
| 4 | Insider transaction | Aug 22, 2024 | Aug 20, 2024 |
| 4 | Insider transaction | Aug 20, 2024 | Aug 15, 2024 |
| 3 | Initial insider ownership | Aug 20, 2024 | Aug 15, 2024 |
| 4 | Insider transaction | Aug 20, 2024 | Aug 15, 2024 |
| 4 | Insider transaction | Aug 19, 2024 | Aug 15, 2024 |
| 4 | Insider transaction | Aug 16, 2024 | Aug 14, 2024 |
| 8-K |
Current report
Officer or director change
|
Aug 16, 2024 | Aug 12, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2024 | Aug 9, 2024 |
| 10-Q | Quarterly report | Aug 9, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 29, 2024 | Jul 29, 2024 |
| 8-K |
Current report
Officer or director change, Other events
|
Jul 18, 2024 | Jul 15, 2024 |
| 4 | Insider transaction | Jul 17, 2024 | Jul 15, 2024 |
| 3 | Initial insider ownership | Jul 17, 2024 | Jul 15, 2024 |
| 8-K |
Current report
Officer or director change
|
Jul 12, 2024 | Jul 9, 2024 |
| EFFECT | Filing | Jul 9, 2024 | — |
| SC 13D/A | Amended ownership over 5% (active) | Jul 5, 2024 | — |
| CORRESP | Letter to the SEC | Jul 5, 2024 | — |
| S-1/A | Amended registration statement | Jul 3, 2024 | — |
| 4 | Insider transaction | Jun 27, 2024 | Jun 21, 2024 |
| S-1/A | Amended registration statement | Jun 17, 2024 | — |
| S-8 | Employee stock plan registration | Jun 17, 2024 | — |
| 8-K |
Current report
Other events
|
Jun 10, 2024 | Jun 6, 2024 |
| 4 | Insider transaction | May 31, 2024 | May 29, 2024 |
| 4 | Insider transaction | May 29, 2024 | May 28, 2024 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SER (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- AL
- Headquarters
- Huntsville, AL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1708599
- Former names
- AgeX Therapeutics, Inc. (until Apr 1, 2024)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.